Hemophilia Market Size, Share, Trends, Growth and Forecast 2032
Hemophilia Market - By Disease Type (Hemophilia A, Hemophilia B, and Others), By Therapy (Gene Therapy, Replacement Therapy, and Others), By Product Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 13.01 Billion | USD 23.08 Billion | 6.58% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Hemophilia Market, 2015–2025 (USD Billion)
- 2.2. Hemophilia Market: Snapshot
- Chapter 3. Global Hemophilia Market– Industry Analysis
- 3.1. Hemophilia Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Focus on new drug development along with favorable government pulicies for curbing the disease is likely to prompt the expansion of hemophilia market over the forecast timespan.
- 3.2.2. Rise in the awareness about rare disease such as hemophilia and growing efforts made by both private & public healthcare research organizations to produce drugs for effectively treating the disorder will impel the business growth.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Disease Type
- 3.4.2. Market attractiveness analysis By Therapy
- 3.4.3. Market attractiveness analysis By Product Type
- Chapter 4. Global Hemophilia Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Hemophilia Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Hemophilia Market– Disease Type Analysis
- 5.1. Global Hemophilia Market overview: By Disease Type
- 5.1.1. Global Hemophilia Market share, By Disease Type , 2019 and 2025
- 5.2. Hemophilia A
- 5.2.1. Global Hemophilia Market By Hemophilia A , 2015–2025 (USD Billion)
- 5.3. Hemophilia B
- 5.3.1. Global Hemophilia Market By Hemophilia B, 2015–2025 (USD Billion)
- 5.4. Others
- 5.4.1. Global Hemophilia Market By Others , 2015–2025 (USD Billion)
- 5.1. Global Hemophilia Market overview: By Disease Type
- Chapter 6. Global Hemophilia Market– Therapy Analysis
- 6.1. Global Hemophilia Market overview: By Therapy
- 6.1.1. Global Hemophilia Market share, By Therapy , 2019 and 2025
- 6.2. Gene Therapy
- 6.2.1. Global Hemophilia Market By Gene Therapy, 2015–2025 (USD Billion)
- 6.3. Replacement Therapy
- 6.3.1. Global Hemophilia Market By Replacement Therapy, 2015–2025 (USD Billion)
- 6.4. Others
- 6.4.1.1. Global Hemophilia Market By Others, 2015–2025 (USD Billion)
- 6.1. Global Hemophilia Market overview: By Therapy
- Chapter 7. Global Hemophilia Market– Product Type Analysis
- 7.1. Global Hemophilia Market overview: By Product Type
- 7.1.1. Global Hemophilia Market share, By Product Type , 2019 and 2025
- 7.2. Plasma-Derived Coagulation Factor Concentrates
- 7.2.1. Global Hemophilia Market By Plasma-Derived Coagulation Factor Concentrates, 2015–2025 (USD Billion)
- 7.3. Recombinant Coagulation Factor Concentrates
- 7.3.1. Global Hemophilia Market By Recombinant Coagulation Factor Concentrates, 2015–2025 (USD Billion)
- 7.4. Others
- 7.4.1.1. Global Hemophilia Market By Others, 2015–2025 (USD Billion)
- 7.1. Global Hemophilia Market overview: By Product Type
- Chapter 8. Company Profiles
- 8.1. BioMarin Pharmaceutical, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Bayer AG
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Kedrion
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. CSL Behring
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Pfizer, Inc.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Novo Nordisk
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Sanofi (Genzyme Corporation)
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Roche (Chugai Pharmaceutical Co.)
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Takeda Pharmaceutical (Shire Plc.)
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.1. BioMarin Pharmaceutical, Inc.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Hemophilia Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Hemophilia Market attractiveness, By Disease Type
6. Global Hemophilia Market attractiveness, By Therapy
7. Global Hemophilia Market attractiveness, By Product Type
8. Global Hemophilia Market Share by Disease Type ,2019 and 2025 (USD Billion)
9. Global Hemophilia Market by Hemophilia A ,2015–2025 (USD Billion)
10. Global Hemophilia Market by Hemophilia B ,2015–2025 (USD Billion)
11. Global Hemophilia Market by Others ,2015–2025 (USD Billion)
12. Global Hemophilia Market Share by Therapy ,2019 and 2025 (USD Billion)
13. Global Hemophilia Market by Gene Therapy,2015–2025 (USD Billion)
14. Global Hemophilia Market by Replacement Therapy,2015–2025 (USD Billion)
15. Global Hemophilia Market by Others,2015–2025 (USD Billion)
16. Global Hemophilia Market Share by Product Type ,2019 and 2025 (USD Billion)
17. Global Hemophilia Market by Plasma-Derived Coagulation Factor Concentrates,2015–2025 (USD Billion)
18. Global Hemophilia Market by Recombinant Coagulation Factor Concentrates,2015–2025 (USD Billion)
19. Global Hemophilia Market by Others,2015–2025 (USD Billion)
20. Global Hemophilia Market share, by Region, 2019 and 2025
21. North America Hemophilia Market, 2015–2025 (USD Billion)
22. Europe Hemophilia Market, 2015–2025 (USD Billion)
23. Asia Pacific Hemophilia Market, 2015–2025 (USD Billion)
24. Latin America Hemophilia Market, 2015–2025 (USD Billion)
25. The Middle East and Africa Hemophilia Market, 2015–2025 (USD Billion)
Table Of Tables
List of Tables
1. Global Hemophilia Market: snapshot
2. Drivers of the Hemophilia Market: impact analysis
3. North America Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
4. North America Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
5. North America Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
6. The U.S. Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
7. The U.S. Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
8. The U.S. Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
9. Rest of North America Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
10. Rest of North America Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
11. Rest of North America Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
12. Europe Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
13. Europe Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
14. Europe Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
15. UK Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
16. UK Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
17. UK Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
18. France Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
19. France Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
20. France Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
21. Germany Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
22. Germany Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
23. Germany Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
24. Rest of Europe Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
25. Rest of Europe Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
26. Rest of Europe Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
27. Asia Pacific Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
28. Asia Pacific Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
29. Asia Pacific Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
30. China Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
31. China Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
32. China Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
33. Japan Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
34. Japan Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
35. Japan Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
36. India Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
37. India Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
38. India Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
39. Rest of Asia Pacific Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
40. Rest of Asia Pacific Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
41. Rest of Asia Pacific Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
42. Latin America Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
43. Latin America Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
44. Latin America Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
45. Brazil Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
46. Brazil Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
47. Brazil Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
48. Rest of Latin America Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
49. Rest of Latin America Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
50. Rest of America Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
51. The Middle East and Africa Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
52. The Middle East and Africa Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
53. The Middle East and Africa Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
54. Saudi Arabia Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
55. Saudi Arabia Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
56. Saudi Arabia Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
57. South Africa Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
58. South Africa Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
59. South Africa Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
60. Rest of the Middle East & Africa Hemophilia Market revenue, By Disease Type , 2015–2025 (USD Billion)
61. Rest of the Middle East & Africa Hemophilia Market revenue, By Therapy , 2015–2025 (USD Billion)
62. Rest of the Middle East & Africa Hemophilia Market revenue, By Product Type , 2015–2025 (USD Billion)
Methodology
FrequentlyAsked Questions
Focus on new drug development along with favorable government policies for curbing the disease is likely to prompt the expansion of hemophilia market over the forecast timespan. In addition to this, rise in the awareness about rare disease such as hemophilia and growing efforts made by both private & public healthcare research organizations to produce drugs for effectively treating the disorder will impel the business growth. Apparently, huge allocation of funds by giant pharma firms in research & development to find new ways of treating the genetic disease will proliferate the expansion of the hemophilia industry over the forecast timespan.
Furthermore, enhanced distribution networking facility of the mammoth players in the pharmaceutical industry will culminate into huge market demand over the forecasting timeframe.
global Hemophilia Market, estimating its value at USD 13.01 Billion in 2023, with projections indicating that it will reach USD 23.08 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 6.58% over the forecast period 2024-2032.
North America is likely to make noteworthy contributions towards overall market revenue during 2024-2032. The surge in the expansion of market in the sub-continent over the estimated timespan is due to increase in the number of hemophilia cases in the countries like the U.S. In addition to this, rise in the use of prophylaxis therapy for hemophilia in the region will promulgate the business growth in the sub-continent over the forecast timespan. Presence of behemoth pharmaceutical firms as well as healthcare service providers in the countries such as Canada and the U.S. are expected to boost the regional market trends.
The key players profiled in the report include BioMarin Pharmaceutical, Inc.; Bayer AG; Kedrion; CSL Behring; Pfizer, Inc.; Novo Nordisk; Sanofi (Genzyme Corporation); Roche (Chugai Pharmaceutical Co.); and Takeda Pharmaceutical (Shire Plc.).
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed